Patients in the future could go to superstores to get medical diagnoses by leaving blood or saliva on a BlackBerry-like tool as well as purchase personalized drugs, industry executive G. Steven Burrill said at a conference. At the gathering, an Ernst & Young official said personalized medicine will restructure business models by allowing drugmakers to market costly tailored treatments in small volumes.

Related Summaries